CMS today issued its final National Coverage Determination (NCD) on renal denervation (RDN), a major win for Medtronic and ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced new advances in surgical robotic technology with physical AI ...

Medline announced today that it publicly filed a registration statement with the SEC related to a proposed initial public ...

Pleural Dynamics today announced positive results from a prospective, multicenter study evaluating its ACES device.

Orchestra BioMed (Nasdaq:OBIO) announced today that it entered into a termination and right of first refusal agreement with ...

Zimmer Biomet (NYSE: ZBH) announced that it received FDA breakthrough device designation for its iodine-treated total hip ...

AtriCure (Nasdaq:ATRC) announced the first patient enrolled in its BoxX-NoAF clinical trial evaluating its cardiac therapy ...

Abbott (NYSE: ABT) reported new study findings supporting the use of its Tendyne transcatheter mitral valve replacement (TMVR ...

Remedy Robotics has entered a strategic partnership with the Society of Vascular and Interventional Neurology’s Mission ...

Edwards Lifesciences (NYSE: EW) today shared new data demonstrating successful outcomes with its mitral and tricuspid ...

Medtronic today announced the first results from the high cardiovascular risk cohort of its SPYRAL AFFIRM study.

Boston Scientific also reported findings from the ALLIANCE registry looking at 1,800 Agent patients in Japan. It assessed the ...